Wong WWL - Search Results

1

Economic evaluation of pharmacists prescribing for minor ailments in Ontario, Canada: a cost-minimization analysis.

Kim JJ, Tian AH, Pham L, Nakhla N, Houle SKD, Wong WWL, Alsabbagh MW. Kim JJ, et al. Among authors: wong wwl. Int J Pharm Pract. 2021 May 25;29(3):228-234. doi: 10.1093/ijpp/riab006. Int J Pharm Pract. 2021. PMID: 33778880 Free PMC article.

2

Cost-utility analysis of offering a novel remunerated community pharmacist consultation service on influenza vaccination for seniors in Ontario, Canada.

Pullagura GR, Waite NM, Houle SKD, Violette R, Wong WWL. Pullagura GR, et al. Among authors: wong wwl. J Am Pharm Assoc (2003). 2019 Jul-Aug;59(4):489-497.e1. doi: 10.1016/j.japh.2019.02.011. Epub 2019 Apr 9. J Am Pharm Assoc (2003). 2019. PMID: 30979576

3

Cost-Effectiveness of Tenofovir Alafenamide for Treatment of Chronic Hepatitis B in Canada.

Tian F, Houle SKD, Alsabbagh MW, Wong WWL. Tian F, et al. Among authors: wong wwl. Pharmacoeconomics. 2020 Feb;38(2):181-192. doi: 10.1007/s40273-019-00852-y. Pharmacoeconomics. 2020. PMID: 31691902

4

Economic evaluation of compression stockings for the prevention of venous leg ulcer recurrence in Ontario.

Djalalov S, Sehatzadeh S, Keast DH, Wong WW. Djalalov S, et al. J Wound Care. 2020 Mar 2;29(3):141-151. doi: 10.12968/jowc.2020.29.3.141. J Wound Care. 2020. PMID: 32160090

5

Lenvatinib Versus Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Cost-Utility Analysis.

Kim JJ, McFarlane T, Tully S, Wong WWL. Kim JJ, et al. Among authors: wong wwl. Oncologist. 2020 Mar;25(3):e512-e519. doi: 10.1634/theoncologist.2019-0501. Epub 2019 Nov 20. Oncologist. 2020. PMID: 32162815 Free PMC article.

6

The emergency department as a setting-specific opportunity for population-based hepatitis C screening: An economic evaluation.

Mendlowitz AB, Naimark D, Wong WWL, Capraru C, Feld JJ, Isaranuwatchai W, Krahn M. Mendlowitz AB, et al. Among authors: wong wwl. Liver Int. 2020 Jun;40(6):1282-1291. doi: 10.1111/liv.14458. Epub 2020 Apr 30. Liver Int. 2020. PMID: 32267604

7

Cost-effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosis.

Chan J, Kim JJ, Barrett BK, Hamadeh A, Feld JJ, Wong WWL. Chan J, et al. Among authors: wong wwl. J Viral Hepat. 2021 Feb;28(2):260-267. doi: 10.1111/jvh.13419. Epub 2020 Nov 15. J Viral Hepat. 2021. PMID: 33065774

8

Cost-effectiveness of obeticholic acid for the treatment of non-alcoholic steatohepatitis: An early economic evaluation.

Tran CP, Kim JJ, Feld JJ, Wong WW. Tran CP, et al. Can Liver J. 2021 Nov 11;4(4):360-369. doi: 10.3138/canlivj-2021-0011. eCollection 2021 Fall. Can Liver J. 2021. PMID: 35989894 Free PMC article.

9

Cost Effectiveness of Implementing a Universal Birth Hepatitis B Vaccination Program in Ontario.

Kim JJ, Alsabbagh W, Wong WWL. Kim JJ, et al. Among authors: wong wwl. Pharmacoeconomics. 2023 Apr;41(4):413-425. doi: 10.1007/s40273-022-01236-5. Epub 2023 Jan 28. Pharmacoeconomics. 2023. PMID: 36708500

10

Health utilities in adults with hemophilia A: A retrospective cohort study.

Hirniak S, Edginton AN, Iorio A, Alsabbagh MW, Hajducek DM, Wong WW. Hirniak S, et al. Haemophilia. 2024 May;30(3):733-742. doi: 10.1111/hae.14979. Epub 2024 Mar 20. Haemophilia. 2024. PMID: 38506967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters